Peripheral immune cells in the pathology of traumatic brain injury?

Current Opinion in Critical Care

Volumn 17, Issue 2, 2011, Pages 122-130

  Rhodes, Jonathan ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

inflammation; leucocytes; traumatic brain injury

Indexed keywords

ANTIBODY; BETA2 INTEGRIN; CD11D ANTIBODY; CORTICOSTEROID; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PADGEM PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

BRAIN CONTUSION; BRAIN ISCHEMIA; CELL INFILTRATION; CRANIOTOMY; DRUG MEGADOSE; ENCEPHALITIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE; LEUKOCYTE MIGRATION; MACROPHAGE; MICROGLIA; NATURAL KILLER CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SPINAL CORD COMPRESSION; T LYMPHOCYTE; TRAUMATIC BRAIN INJURY;

BRAIN INJURIES; BRAIN ISCHEMIA; HUMANS; LEUKOCYTES;

EID: 79953112128     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283447948     Document Type: Review

References (135)

1. Soares HD, Hicks RR, Smith D, McIntosh TK. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 1995;15:8223-8233. (Pubitemid 26006925)
2. Csuka E, Hans VH, Ammann E, et al. Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreport 2000;11:2587-2590. (Pubitemid 30622313)
3. Biagas KV, Uhl MW, Schiding JK, et al. Assessment of posttraumatic polymorphonuclear leukocyte accumulation in rat brain using tissue myeloperoxidase assay and vinblastine treatment. J Neurotrauma 1992;9:363-371. (Pubitemid 23031061)
4. Clark RS, Schiding JK, Kaczorowski SL, et al. Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. J Neurotrauma 1994;11:499-506. (Pubitemid 24347273)
5. Holmin S, Mathiesen T, Shetye J, Biberfeld P. Intracerebral inflammatory response to experimental brain contusion. Acta Neurochir (Wien) 1995;132(1-3): 110-119.
6. Hausmann R, Kaiser A, Lang C, et al. A quantitative immunohistochemical study on the time-dependent course of acute inflammatory cellular response to human brain injury. Int J Legal Med 1999;112:227-232. (Pubitemid 29319111)
7. Garcia JH, Kamijyo Y. Cerebral infarction. Evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J Neuropathol Exp Neurol 1974;33:408-421.
8. Garcia JH, Liu KF, Yoshida Y, et al. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994;144:188-199. (Pubitemid 24158372)
9. Clark RK, Lee EV, White RF, et al. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull 1994;35:387-392. (Pubitemid 24332684)
10. Jander S, Kraemer M, Schroeter M, et al. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 1995;15:42-51.
11. Furie MB, Randolph GJ. Chemokines and tissue injury. Am J Pathol 1995;146:1287-1301.
12. Wahl SM, Feldman GM, McCarthy JB. Regulation of leukocyte adhesion and signaling in inflammation and disease. J Leukoc Biol 1996;59:789-796. (Pubitemid 26238473)
13. Johnston B, Butcher EC. Chemokines in rapid leukocyte adhesion triggering and migration. Semin Immunol 2002;14:83-92. (Pubitemid 34879384)
14. Carlos TM, Clark RS, Franicola-Higgins D, et al. Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J Leukoc Biol 1997;61:279-285. (Pubitemid 27149906)
15. Isaksson J, Lewen A, Hillered L, Olsson Y. Up-regulation of intercellular adhesion molecule 1 in cerebral microvessels after cortical contusion trauma in a rat model. Acta Neuropathol 1997;94:16-20. (Pubitemid 27289097)
16. Knoblach SM, Faden AI. Administration of either antiintercellular adhesion molecule-1 or a nonspecific control antibody improves recovery after traumatic brain injury in the rat. J Neurotrauma 2002;19:1039-1050.
17. Whalen MJ, Carlos TM, Dixon CE, et al. Effect of traumatic brain injury in mice deficient in intercellular adhesion molecule-1: assessment of histopathologic and functional outcome. J Neurotrauma 1999;16:299-309. (Pubitemid 29200823)
18. McKeating EG, Andrews PJ, Mascia L. Leukocyte adhesion molecule profiles and outcome after traumatic brain injury. Acta Neurochir Suppl 1998;71:200-202. (Pubitemid 128444396)
19. Taupin V, Toulmond S, Serrano A, et al. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre and posttraumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 1993;42:177-185.
20. Fan L, Young PR, Barone FC, et al. Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res 1996;36:287-291. (Pubitemid 26095588)
21. Rostworowski M, Balasingam V, Chabot S, et al. Astrogliosis in the neonatal and adult murine brain posttrauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma. J Neurosci 1997;17:3664-3674. (Pubitemid 27200593)
22. Yan HQ, Banos MA, Herregodts P, et al. Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury. Eur J Immunol 1992;22:2963-2971.
23. Fan L, Young PR, Barone FC, et al. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res Mol Brain Res 1995;30:125-130.
24. Hans V, Kossmann T, Lenzlinger PM, et al. Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid. J Cereb Blood Flow Metab 1999;19:184-194. (Pubitemid 29284267)
25. Rhodes JK, Andrews PJ, Holmes MC, Seckl JR. Expression of interleukin-6 messenger RNA in a rat model of diffuse axonal injury. Neurosci Lett 2002;335:1-4. (Pubitemid 35379801)
26. Kamm K, Vanderkolk W, Lawrence C, et al. The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J Trauma 2006;60:152-157.
27. Shohami E, Novikov M, Bass R, et al. Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab 1994;14:615-619. (Pubitemid 24198404)
28. Knoblach SM, Fan L, Faden AI. Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J Neuroimmunol 1999;95(1-2): 115-125. (Pubitemid 29173028)
29. Zhu T, Yao Z, Yuan HN, et al. Changes of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 in brain and plasma after brain injury in rats. Chin J Traumatol 2004;7:32-35. (Pubitemid 38208512)
30. Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of tumor necrosis factor in head injury. J Neuroimmunol 1990;30(2-3): 213-217. (Pubitemid 20362754)
31. Ross SA, Halliday MI, Campbell GC, et al. The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurgery 1994;8:419-425. (Pubitemid 24282529)
32. Morganti-Kossman MC, Lenzlinger PM, Hans V, et al. Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Molecular Psychiatry 1997;2:133-136. (Pubitemid 27166031)
33. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, et al. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol 1999;101:211-221. (Pubitemid 29516464)
34. Hayakata T, Shiozaki T, Tasaki O, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004;22:102-107. (Pubitemid 40228186)
35. Shiozaki T, Hayakata T, Tasaki O, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 2005;23:406-410. (Pubitemid 40571662)
36. McClain CJ, Cohen D, Ott L, et al. Ventricular fluid interleukin-1 activity in patients with head injury. J Lab Clin Med 1987;110:48-54. (Pubitemid 17103984)
37. McClain C, Cohen D, Phillips R, et al. Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury [see comments]. J Lab Clin Med 1991;118:225-231.
38. Heesen M, Deinsberger W, Dietrich GV, et al. Increase of interleukin-6 plasma levels after elective craniotomy: influence of interleukin-10 and catecholamines. Acta Neurochir (Wien) 1996;138:77-80. (Pubitemid 26043367)
39. Kossmann T, Hans VH, Imhof HG, et al. Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 1995;4:311-317.
40. Kossmann T, Hans V, Imhof HG, et al. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 1996;713:143-152. (Pubitemid 26114837)
41. Osuka K, Suzuki Y, Saito K, et al. Changes in serum cytokine concentrations after neurosurgical procedures. Acta Neurochir (Wien) 1996;138:970-976. (Pubitemid 26290174)
42. Bell MJ, Kochanek PM, Doughty LA, et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma 1997;14:451-457. (Pubitemid 27338083)
43. Hans VH, Kossmann T, Joller H, et al. Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma. Neuroreport 1999;10:409-412. (Pubitemid 29104822)
44. McKeating EG, Andrews PJ, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth 1997;78:520-523. (Pubitemid 27226363)
45. Hillman J, Aneman O, Persson M, et al. Variations in the response of interleukins in neurosurgical intensive care patients monitored using intracerebral microdialysis. J Neurosurg 2007;106:820-825. (Pubitemid 46698667)
46. Wong D, Dorovini-Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 1992;39:11-21.
47. Gourin CG, Shackford SR. Influence of percussion trauma on expression of intercellular adhesion molecule-1 (ICAM-1) by human cerebral microvascular endothelium. J Trauma 1996;41:129-135. (Pubitemid 26250883)
48. Dore-Duffy P, Washington RA, Balabanov R. Cytokine-mediated activation of cultured CNS microvessels: a system for examining antigenic modulation of CNS endothelial cells, and evidence for long-term expression of the adhesion protein E-selectin. J Cereb Blood Flow Metab 1994;14:837-844.
49. Bell MD, Taub DD, Perry VH. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 1996;74:283-292. (Pubitemid 26291164)
50. Hausmann EH, Berman NE, Wang YY, et al. Selective chemokine mRNA expression following brain injury. Brain Res 1998;788:49-59. (Pubitemid 28202143)
51. Bajetto A, Bonavia R, Barbero S, et al. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 2001;22:147-184. (Pubitemid 32706335)
52. Otto VI, Stahel PF, Rancan M, et al. Regulationofchemokinesand chemokine receptors after experimental closed head injury. Neuroreport 2001;12:2059-2064. (Pubitemid 32553731)
53. Valles A, Grijpink-Ongering L, de Bree FM, et al. Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival. Neurobiol Dis 2006;22:312-322.
54. Rhodes JK, Sharkey J, Andrews PJ. The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat. J Neurotrauma 2009;26:507-525.
55. Glabinski AR, Balasingam V, Tani M, et al. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol 1996;156:4363-4368. (Pubitemid 26165835)
56. Berman JW, Guida MP, Warren J, et al. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 1996;156:3017-3023. (Pubitemid 126660652)
57. Muessel MJ, Berman NE, Klein RM. Early and specific expression of monocyte chemoattractant protein-1 in the thalamus induced by cortical injury. Brain Res 2000;870:211-221. (Pubitemid 30408423)
58. Mellergard P, Aneman O, Sjogren F, et al. Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery 2008;62:151-157. (Pubitemid 351640303)
59. Stefini R, Catenacci E, Piva S, et al. Chemokine detection in the cerebral tissue of patients with posttraumatic brain contusions. J Neurosurg 2008;108:958-962. (Pubitemid 351656844)
60. Kossmann T, Stahel PF, Lenzlinger PM, et al. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 1997;17:280-289. (Pubitemid 27161371)
61. Losy J, Zaremba J. Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 2001;32:2695-2696. (Pubitemid 33055326)
62. Aloisi F, Care A, Borsellino G, et al. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol 1992;149:2358-2366.
63. Ehrlich LC, Hu S, Sheng WS, et al. Cytokine regulation of human microglial cell IL-8 production. J Immunol 1998;160:1944-1948. (Pubitemid 28106484)
64. Oh JW, Schwiebert LM, Benveniste EN. Cytokine regulation of CC and CXC chemokine expression by human astrocytes. J Neurovirol 1999;5:82-94. (Pubitemid 29051882)
65. Janabi N, Hau I, Tardieu M. Negative feedback between prostaglandin and alpha-and beta-chemokine synthesis in human microglial cells and astrocytes. J Immunol 1999;162:1701-1706. (Pubitemid 29307048)
66. Hua LL, Lee SC. Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia 2000;30:74-81. (Pubitemid 30172154)
67. Croitoru-Lamoury J, Guillemin GJ, Boussin FD, et al. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 2003;41:354-370. (Pubitemid 36314149)
68. Barna BP, Pettay J, Barnett GH, et al. Regulation of monocyte chemoattractant protein-1 expression in adult human nonneoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor. J Neuroimmunol 1994;50:101-107. (Pubitemid 24043076)
69. Hurwitz AA, Lyman WD, Berman JW. Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1. J Neuroimmunol 1995;57:193-198.
70. Peterson PK, Hu S, Salak-Johnson J, et al. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis 1997;175:478-481. (Pubitemid 27052263)
71. Otto VI, Heinzel-Pleines UE, Gloor SM, et al. sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells. J Neurosci Res 2000;60:733-742. (Pubitemid 30399544)
72. Hayashi M, Luo Y, Laning J, et al. Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J Neuroimmunol 1995;60:143-150.
73. Calvo CF, Yoshimura T, Gelman M, Mallat M. Production of monocyte chemotactic protein-1 by rat brain macrophages. Eur J Neurosci 1996;8:1725-1734. (Pubitemid 26289690)
74. Rhodes JK. An investigation of chemokine expression and modulation following traumatic brain injury; PhD Thesis, University of Edinburgh, 2009.
75. Glabinski AR, Bielecki B, Kolodziejski P, et al. TNF-alpha microinjection upregulates chemokines and chemokine receptors in the central nervous system without inducing leukocyte infiltration. J Interferon Cytokine Res 2003;23:457-466. (Pubitemid 37034584)
76. Anthony D, Dempster R, Fearn S, et al. CXC chemokines generate agerelated increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol 1998;8:923-926. (Pubitemid 28371758)
77. Colton CA, Gilbert DL. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987;223:284-288.
78. Chao CC, Hu S, Molitor TW, et al. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992;149:2736-2741.
79. Giulian D, Vaca K, Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 1993;13:29-37. (Pubitemid 23028725)
80. Dinkel K, Dhabhar FS, Sapolsky RM. Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures. Proc Natl Acad Sci USA 2004;101:331-336. (Pubitemid 38084250)
81. Nguyen HX, O'Barr TJ, Anderson AJ. Polymorphonuclear leukocytes promote neurotoxicity through release of matrix met alloproteinases, reactive oxygen species, and TNF-alpha. J Neurochem 2007;102:900-912. (Pubitemid 47057309)
82. Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 1994;28:221-268.
83. Clark WM, Hazel JS, Coull BM. Lazaroids. CNS pharmacology and current research. Drugs 1995;50:971-983.
84. Siesjo BK. Basic mechanisms of traumatic brain damage. Ann Emerg Med 1993;22:959-969. (Pubitemid 23163036)
85. Royston D. Free radicals. Formation, function and potential relevance in anaesthesia. Anaesthesia 1988;43:315-320.
86. Love S. Oxidative stress in brain ischemia. Brain Pathol 1999;9:119-131. (Pubitemid 29056523)
87. Giulian D, Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 1993;24(Suppl 12): Suppl-90.
88. Piani D, Spranger M, Frei K, et al. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids ratherthan reactive oxygen intermediates and cytokines. Eur J Immunol 1992;22:2429-2436.
89. Beck KD, Nguyen HX, Galvan MD, et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010;133:2-47. Demonstrates that macrophage recruitment, perhaps of a different subtype to those involved in acute inflammation, occurs late after injury. This study also suggests that late inflammatory events associated with resolution of inflammation and repair should not be inhibited.
90. Stahel PF, Morganti-Kossmann MC, Kossmann T. The role of the complement system in traumatic brain injury. Brain Res Brain Res Rev 1998;27:243-256. (Pubitemid 28389310)
91. del Zoppo GJ, Schmid-Schonbein GW, Mori E, et al. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991;22:1276-1283.
92. Dutka AJ, Kochanek PM, Hallenbeck JM. Influence of granulocytopenia on canine cerebral ischemia induced by air embolism. Stroke 1989;20:390-395. (Pubitemid 19080098)
93. Helps SC, Gorman DF. Air embolism of the brain in rabbits pretreated with mechlorethamine. Stroke 1991;22:351-354.
94. Mori E, del Zoppo GJ, Chambers JD, et al. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992;23:712-718.
95. Connolly ES Jr, Winfree CJ, Springer TA, et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 1996;97:209-216. (Pubitemid 26021710)
96. de Vries HE, Blom-Roosemalen MC, van Oosten M, et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 1996;64:37-43. (Pubitemid 26052072)
97. Matsuo Y, Kihara T, Ikeda M, et al. Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. J Cereb Blood Flow Metab 1995;15:941-947.
98. Shiga Y, Onodera H, Kogure K, et al. Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci Lett 1991;125:110-112.
99. Matsuo Y, Onodera H, Shiga Y, et al. Correlation between myeloperoxidasequantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 1994;25:1469-1475. (Pubitemid 24198597)
100. Matsuo Y, Onodera H, Shiga Y, et al. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res 1994;656:344-352. (Pubitemid 24277119)
101. Chen H, Chopp M, Zhang RL, et al. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann Neurol 1994;35:458-463. (Pubitemid 24107854)
102. Chopp M, Zhang RL, Chen H, et al. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 1994;25:869-875.
103. Zhang ZG, Chopp M, Tang WX, et al. Postischemic treatment (2-4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat. Brain Res 1995;698:79-85.
104. Zhang RL, Chopp M, Li Y, et al. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 1994;44:1747-1751. (Pubitemid 24286659)
105. Jiang N, Moyle M, Soule HR, et al. Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann Neurol 1995;38:935-942. (Pubitemid 26004599)
106. Soriano SG, Coxon A, Wang YF, et al. Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke 1999;30:134-139. (Pubitemid 29029454)
107. Weaver KD, Branch CA, Hernandez L, et al. Effect of leukocyte-endothelial adhesion antagonism on neutrophil migration and neurologic outcome after cortical trauma. J Trauma 2000;48:1081-1090. (Pubitemid 30436824)
108. Whalen MJ, Carlos TM, Dixon CE, et al. Reduced brain edema after traumatic brain injury in mice deficient in P-selectin and intercellular adhesion molecule-1. J Leukoc Biol 2000;67:160-168.
109. Zhang RL, Chopp M, Jiang N, et al. Antiintercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 1995;26:1438-1442.
110. Isaksson J, Hillered L, Olsson Y. Cognitive and histopathological outcome after weight-drop brain injury in the rat: influence of systemic administration of monoclonal antibodies to ICAM-1. Acta Neuropathol 2001;102:246-256. (Pubitemid 32816145)
111. Garcia JH, Liu KF, Bree MP. Effects of CD11 b/18 monoclonal antibody on rats with permanent middle cerebral artery occlusion. Am J Pathol 1996;148:241-248. (Pubitemid 26019658)
112. Zhang L, Zhang ZG, Zhang RL, et al. Effects of a selective CD11 b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 2003;34:1790-1795. (Pubitemid 36842647)
113. Nishimura Y, Takei Y, Kawano S, et al. The F (ab') 2 fragment of an anti-ICAM-1 monoclonal antibody attenuates liver injury after orthotopic liver transplantation. Transplantation 1996;61:99-104. (Pubitemid 126444285)
114. Semple BD, Bye N, Ziebell JM, Morganti-Kossmann MC. Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiol Dis 2010;40:394-403. Provides contemporary data that inhibition of leucocyte recruitment in TBI is beneficial, using an approach focusing on the inhibition of chemokine function. The importance of timing of assessment is also emphasized.
115. Semple BD, Bye N, Rancan M, et al. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/-mice. J Cereb Blood Flow Metab 2010;30:769-782. Provides contemporary data that inhibition of leucocyte recruitment in TBI is beneficial, using an approach focusing on the inhibition of chemokine function. The importance of timing of assessment is also emphasized. This study also suggests that the role of chemokines in the inflammatory response is more complex than currently appreciated. Inhibition of early chemokine events altered the late recruitment of monocytes into injured tissue. The mechanism of this action remains unclear.
116. Chen Y, Hallenbeck JM, Ruetzler C, et al. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 2003;23:748-755. (Pubitemid 36713680)
117. Schilling M, Strecker JK, Ringelstein EB, et al. The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice. Brain Res 2009;1289:79-84. Novel methodology overcoming the difficulties of differentiating macrophages from microglia allowing the temporal profile of monocytic cell recruitment after ischaemic injury to be more clearly resolved.
118. Schilling M, Strecker JK, Schabitz WR, et al. Effects of monocyte chemoat-tractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 2009;161:806-812. Novel methodology overcoming the difficulties of differentiating macrophages from microglia allowing the temporal profile of monocytic cell recruitment after ischaemic injury to be more clearly resolved.
119. Schroeter M, Jander S, Huitinga I, et al. Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia. Stroke 1997;28:382-386. (Pubitemid 27097009)
120. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-2428.
121. Hughes PM, Allegrini PR, Rudin M, et al. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 2002;22:308-317. (Pubitemid 34203058)
122. Savill JS, Wyllie AH, Henson JE, et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-875. (Pubitemid 19080618)
123. Heasman SJ, Giles KM, Ward C, et al. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implicationsforthe resolution of inflammation. J Endocrinol 2003;178:29-36. (Pubitemid 36927006)
124. Koedel U, Frankenberg T, Kirschnek S, et al. Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog 2009;5: e1000461. Evidence is presented that the manipulation of neutrophil apoptosis in the central nervous system could reduce damage associated with the inflammatory response.
125. Duffield JS. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond) 2003;104:27-38. (Pubitemid 36249921)
126. Porcheray F, Viaud S, Rimaniol AC, et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005;142:481-489. (Pubitemid 41719844)
127. Wang Y, Wang YP, Zheng G, et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007;72:290-299. (Pubitemid 47172367)
128. Wilson HM, Chettibi S, Jobin C, et al. Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol 2005;167:27-37. (Pubitemid 40884767)
129. Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004;364:1321-1328.
130. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995;154:4719-4725.
131. Saville LR, Pospisil CH, Mawhinney LA, et al. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment. J Neuroimmunol 2004;156(1-2): 42-57. (Pubitemid 39304184)
132. Weaver LC, Gris D, Saville LR, et al. Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an antiintegrin treatment. J Neurotrauma 2005;22:1375-1387. (Pubitemid 43122353)
133. Giulian D, Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 1990;27:33-42. (Pubitemid 20031356)
134. Popovich PG, Guan Z, Wei P, et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 1999;158:351-365. (Pubitemid 29382826)
135. Bellander BM, Lidman O, Ohlsson M, et al. Genetic regulation of microglia activation, complement expression, and neurodegeneration in a rat model of traumatic brain injury. Exp Brain Res 2010;205:103-114.